At a Glance
- Tasks: Lead nonclinical safety strategies for innovative drug development in biologics and peptides.
- Company: AiLux, a pioneering company in drug safety based in Cambridge, UK.
- Benefits: Competitive salary, leadership opportunities, and the chance to shape future safety science.
- Other info: Join a dynamic team and help drive the future of drug safety science.
- Why this job: Make a significant impact on drug safety and innovation in a strategic leadership role.
- Qualifications: Extensive expertise in toxicology, pharmacology, and regulatory submissions required.
The predicted salary is between 60000 - 80000 £ per year.
AiLux is seeking a Senior Director of Drug Safety in Cambridge, UK, to lead and establish its nonclinical safety strategies across innovative drug development. This pivotal role will involve establishing safety assessments for biologics, multi-specific antibodies, and peptide therapeutics, reporting directly to the VP of In Vivo Bioscience.
The ideal candidate will have extensive expertise in toxicology and pharmacology, with a background in overseeing regulatory submissions. This is a strategic leadership role, offering the chance to shape the future of AiLux's safety science capabilities.
Head of Translational Drug Safety — Biologics & Peptides employer: Ailux
AiLux is an exceptional employer, offering a dynamic work environment in the heart of Cambridge, where innovation meets collaboration. Employees benefit from a culture that prioritises professional growth and development, alongside competitive remuneration and comprehensive benefits. Joining AiLux means being part of a forward-thinking team dedicated to advancing drug safety science, with unique opportunities to influence cutting-edge research in biologics and peptides.
